ArticleScientific reports2023

MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia.

Ada Lerma Clavero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.